Page 126 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 126

OVERVIEW OF CARDIOVASCULAR DEVICES  105

                          Laas, J., P. Kleine, et al. (1999). “Orientation of tilting disc and bileaflet aortic valve substitutes for optimal
                            hemodynamics.” Ann Thorac Surg, 68(3):1096–9.
                          Lazar, H. L., Y. Bao, et al. (1999). “Decreased incidence of arterial thrombosis using heparin-bonded intraaortic
                            balloons.” Ann Thorac Surg, 67(2):446–9.
                          Lehner, G., T. Fischlein, et al. (1997). “Endothelialized biological heart valve prostheses in the non-human pri-
                            mate model.” Eur J Cardiothorac Surg, 11(3):498–504.
                          Leon, M. B., P. S. Teirstein, et al. (2001). “Localized intracoronary gamma-radiation therapy to inhibit the recur-
                            rence of restenosis after stenting.” N Engl J Med, 344(4):250–6.
                          Leung, S. K. and C. P. Lau (2000). “Developments in sensor-driven pacing.” Cardiol Clin, 18(1):113–55, ix.
                          Leypoldt, J. K. and A. K. Cheung (1996). “Characterization of molecular transport in artificial kidneys.” Artif
                            Organs, 20(5):381–9.
                          Lim, W. L., Y. T. Chew, et al. (1998). “Steady flow dynamics of prosthetic aortic heart valves: a comparative eval-
                            uation with PIV techniques.” J Biomech, 31(5):411–21.
                          Londrey, G. L., D. E. Ramsey, et al. (1991). “Infrapopliteal bypass for severe ischemia: comparison of autoge-
                            nous vein, composite, and prosthetic grafts.” J Vasc Surg, 13(5):631–6.
                          Mackay, J. and G. A. Mensah. (2004). “The atlas of heart disease and stroke.” Retrieved May 1st, 2008, from
                            http://www.who.int/cardiovascular diseases/resources/atlas/en/index.html.
                          Makarewicz, A. J., L. F. Mockros, et al. (1994). “A pumping artificial lung.” ASAIO J, 40(3):M518–21.
                          Makhijani, V. B., H. Q. Yang, et al. (1997). “Three-dimensional coupled fluid-structure simulation of pericardial
                            bioprosthetic aortic valve function.” ASAIO J, 43(5):M387–92.
                          Maki, D. G., L. Cobb, et al. (1988). “An attachable silver-impregnated cuff for prevention of infection with cen-
                            tral venous catheters: a prospective randomized multicenter trial.” Am J Med, 85(3):307–14.
                          Maki, D. G., D. M. Kluger, et al. (2006). “The risk of bloodstream infection in adults with different intravascu-
                            lar devices: a systematic review of 200 published prospective studies.” Mayo Clin Proc , 81(9):1159–71.
                          Maki, D. G. and L. A. Mermel (1998). Infections due to infusion therapy. Hospital Infections. J. V. Bennett and
                            P. S. Brachman. Philadelphia, PA, USA, Lippincott-Raven Publishers:689–724.
                          Maki, D. G., S. M. Stolz, et al. (1997). “Prevention of central venous catheter-related bloodstream infection by
                            use of an antiseptic-impregnated catheter. A randomized, controlled trial.” Ann Intern Med, 127(4):257–66.
                          Mareels, G., D. S. De Wachter, et al. (2004). “Computational fluid dynamics-analysis of the Niagara hemodial-
                            ysis catheter in a right heart model.” Artif Organs, 28(7):639–48.
                          Mareels, G., R. Kaminsky, et al. (2007). “Particle image velocimetry-validated, computational fluid dynamics-
                            based design to reduce shear stress and residence time in central venous hemodialysis catheters.” ASAIO  J,
                            53(4):438–46.
                          Marin, M. G., J. C. Lee, et al. (2000). “Prevention of nosocomial bloodstream infections: effectiveness of
                            antimicrobial-impregnated and heparin-bonded central venous catheters.” Crit Care Med, 28(9):3332–8.
                          Mathers, C. D. and D. Loncar (2006). “Projections of global mortality and burden of disease from 2002 to 2030.”
                            PLoS Med, 3(11):e442.
                          Mattos, M. A., K. J. Hodgson, et al. (1999). “Vascular stents.” Curr Probl Surg, 36(12):909–1053.
                          McCarthy, P. M. and K. Hoercher (2000). “Clinically available intracorporeal left ventricular assist devices,”
                            Prog Cardiovasc Dis, 43(1):37–46.
                          McGiffin, D. C. and J. K. Kirklin (1995). Chapter 32: Cardiopulmonary bypass for cardiac surgery. Surgery of
                            the Chest. D. C. Sabiston Jr. and F. C. Spencer. Philadelphia, PA. U.S.A., W.B. Saunders. V2:1256–1271.
                          Mehlhorn, U., A. Kroner, et al. (1999). “30 years clinical intra-aortic balloon pumping: facts and figures.” Thorac
                            Cardiovasc Surg., 47 (Suppl 2):298–303.
                          Mendelson, K. and F. I. Schoen (2006). “Heart valve tissue engineering: concepts, approaches, progress, and
                            challenges.” Ann Biomed Eng, 34(12):1799–819.
                          Mermel, L. A., B. M. Farr, et al. (2001). “Guidelines for the management of intravascular catheter-related infections.”
                            Clin Infect Dis, 32(9):1249–72.
                          Merport, M., T. P. Murphy, et al. (2000). “Fibrin sheath stripping versus catheter exchange for the treatment of
                            failed tunneled hemodialysis catheters: randomized clinical trial.” J Vasc Interv Radiol, 11(9):1115–20.
                          Meyer, M. M. (2000). “Renal replacement therapies.” Crit Care Clin, 16(1):29–58.
   121   122   123   124   125   126   127   128   129   130   131